Search - tctmd.com

Displaying 121 - 140 of 577

Sort: Relevancy | Date

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

Presentation TCT 2023

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Muhammad Adil Afzal

October 26, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2023

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Todd Neale

October 24, 2023

Presentation TCT 2023

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

Presenter: Gorav Ailawadi

October 24, 2023

News Daily News

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

Yael L. Maxwell

October 20, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News EACTS 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

Michael O'Riordan

October 11, 2023

News Conference News EACTS 2023

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

Michael O'Riordan

October 09, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

News Daily News

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

L.A. McKeown

September 14, 2023

News Daily News

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

Yael L. Maxwell

September 06, 2023

News Daily News

Rheumatoid Arthritis and Aortic Stenosis: A Plausible Link—Now What?

Shelley Wood

August 01, 2023

News Opinion CV Team Dispatch

August 2023 News Roundup

L.A. McKeown

August 01, 2023

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

News Conference News TVT 2023

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

Shelley Wood

June 08, 2023

News Conference News EuroPCR 2023

AnchorMan LAAO Device Matches Up Well With the Watchman

Todd Neale

May 19, 2023

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Todd Neale

May 18, 2023

Advertisement

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

TCT 444: Mid to Long-Term Outcomes of Transcatheter vs. Surgical Aortic Valve Replacement in Low-Risk Patients with Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone

Mitral Transcatheter Edge-to-Edge Repair in Intermediate and Low-Risk Patients: Rationale, Evidence, and Ongoing Studies

SAVR 5-Year Survival Tops 92% in Low-Risk Patients: STS Registry

What’s Going to Be Hot at TCT 2023

Extrathoracic Should Be Preferred Alternative to Transfemoral TAVI: Registry

AUTHEARTVISIT Reignites RCT vs Real-world Data Debate for AV Repair

October 2023 News Roundup

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Pre-TAVI PCI Linked to More Late Bleeding, With Implications for Survival

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

Rheumatoid Arthritis and Aortic Stenosis: A Plausible Link—Now What?

August 2023 News Roundup

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Surgical Outcomes After Failed TEER: More Insights, Red Flags From CUTTING-EDGE

AnchorMan LAAO Device Matches Up Well With the Watchman

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content